Trial intelligence / Profile preview

Simvastatin versus placebo for polycystic ovary syndrome in young single women

PACTR201707002431613Completed

Sponsor
Minia University
Start
Jan 2013
Modality
Small Molecules
Countries
1
01

Overview

Trial of simvastatin in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Minia University. Primary endpoint: Improvement of the clinical and biochemical abnormalities associated with polycystic ovary syndrome. Started Jan 2013; status: completed.

02

Drugs

simvastatin
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on PACTR201707002431613.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201707002431613.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call